Healthcare News and Research

Latest Healthcare News and Research

Kinetic Concepts 2010 third quarter total revenue increases 2% to $506.7 million

Kinetic Concepts, Inc. today reported third quarter 2010 total revenue of $506.7 million compared to $504.4 million in the third quarter of 2009 and up 2% from the second quarter of 2010.

26 Oct 2010

Prevention of vascular diseases needed to avoid tsunami of cases

Canada urgently needs to focus on prevention of vascular diseases to avoid the burden from the expected tsunami of cases, says noted stroke expert Dr. Robert Côté, delivering the Heart and Stroke Foundation of Canada (HSFC) Lecture at the Canadian Cardiovascular Congress 2010.

26 Oct 2010

PharmaVentures acts as advisor and broker to Dr Reddy's in distribution agreement with Vitabiotics

PharmaVentures Ltd announced today that it had acted as the advisor and broker to the Indian pharmaceutical company Dr Reddy's Laboratories in its successful marketing and distribution agreement with the UK healthcare company Vitabiotics Ltd for a range of nutraceutical products. The agreement provides Dr Reddy's exclusive marketing rights in the Russian/CIS markets for two of Vitabiotics' leading products - Jointace and Dietrim. Vitabiotics will supply these products on a long-term basis from its facilities in Europe.

From Vitabiotics Ltd. 26 Oct 2010

MDI and Westburg enter exclusive distribution agreement for Detect-Ready MRSA panel in Benelux region

Molecular Detection Inc. (MDI), a company developing Detect-Ready™ tests designed to increase the speed and accuracy of infectious disease diagnosis, and life sciences and diagnostics distributor Westburg BV today announced that they have entered into an exclusive agreement for distribution of MDI's Detect-Ready MRSA panel in the Benelux region.

26 Oct 2010

Centene third quarter premium and service revenues increase 9.5% to $1.082 billion

Centene Corporation today announced net earnings from continuing operations for the quarter ended September 30, 2010, of $22.4 million, or $0.44 per diluted share; $0.48 from operations excluding a $0.04 charge for net investment writedowns.

26 Oct 2010

Admissions for medication, drug-related conditions increase by 117% among Americans aged 45 and older

The number of hospital admissions among Americans ages 45 and older for medication and drug-related conditions doubled between 1997 and 2008, according to a new report released today by HHS' Agency for Healthcare Research and Quality. Medication and drug-related conditions include effects of both prescription and over-the-counter medications as well as illicit drugs.

26 Oct 2010

Omeros to develop new drugs for major diseases

The Life Sciences Discovery Fund (LSDF) today announced a $5 million grant to Seattle-based Omeros Corporation (NASDAQ: OMER) to discover, develop, and commercialize new drugs to treat a variety of major diseases. With successful generation of proceeds through partnering and the sales of drugs in the marketplace, an additional outcome of the grant would be establishment of a new non-profit initiative to advance the life sciences sector and improve health and economic growth in Washington state.

26 Oct 2010

New Risk Stratification Index allows important clinical outcomes

Research published in the November issue of Anesthesiology describes development of a new Risk Stratification Index (RSI) that allows important clinical outcomes such as length-of-stay and mortality for surgical patients to be accurately compared among hospitals using only publically available billing data. The new risk stratification system is more accurate than existing outcomes measurements such as the Charlson Comorbidity Index (CCI) and the investigators have made it freely available.

26 Oct 2010

Pfizer's Sutent stands as first-line setting for treating renal cell carcinoma: Survey

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of renal cell carcinoma (RCC), the majority of surveyed European oncologists who favor Pfizer's Sutent indicate that they would switch to an emerging therapy only if it extended progression-free survival (PFS) by at least an additional two to three months, assuming the agent's safety and tolerability profile was comparable to that of Sutent.

26 Oct 2010

Challenges in overcoming communication barriers when treating non-Swedish-speaking patients

The healthcare system faces a challenge in overcoming communication barriers when treating non-Swedish-speaking patients, reveals a thesis from the University of Gothenburg, Sweden.

26 Oct 2010

Francisco Partners to invest in Quantros

Quantros, Inc., a leading provider of healthcare software and services for data management, decision support analytics, and clinical business intelligence, today announced that Francisco Partners, one of the world's largest technology-focused private equity firms, has agreed to make a significant capital investment in the company.

26 Oct 2010

IDC grants MedImmune global rights to GLA adjuvant

Immune Design Corp. (IDC), a privately held biotechnology company developing novel vaccines and immunotherapies for infectious disease and cancer, announced today that it has entered into a license and development agreement with MedImmune for the use and commercialization of IDC’s proprietary Glucopyranosyl Lipid Adjuvant (GLA) as a component in vaccines for select infectious diseases.

26 Oct 2010

DKSH’s distribution centers achieve GMP/GDP certification

On the occasion of DKSH's Annual Logistics and Quality Seminar in Taipei, Business Unit Healthcare organized a Certification Award Ceremony to acknowledge the great success of the certification program. It was presided by Charles Toomey, Executive Vice President Business Unit Healthcare, and Dr. Eize de Boer from SGS (Société Générale de Surveillance).

26 Oct 2010

Beryl redefines focus as patient experience company

Beryl, the leader and pioneer in outsourced healthcare contact center services, announces its redefined focus as a patient experience company. For 25 years, Beryl has focused on making it easier for patients to access information and healthcare providers, which enhances patients' interactions with healthcare systems. While this underlying theme has always been present, redefining its focus ensures that all of Beryl's products and services are developed with a laser focus on their impact on improving the patient experience in healthcare.

26 Oct 2010

Knowledge gaps and unjustified fear common among caregivers of children with MRSA

Knowledge gaps and fear - some of it unjustified - are common among the caregivers of children with a drug-resistant staph bacterium known as MRSA, according to the results of a small study from the Johns Hopkins Children Center. These caregivers thirst for timely, detailed and simple information, the researchers add.

26 Oct 2010

Barbers help customers control high blood pressure

Neighborhood barbers, by conducting a monitoring, education and physician-referral program, can help their African-American customers better control high blood pressure problems that pose special health risks for them, a new study from the Cedars-Sinai Heart Institute shows.

26 Oct 2010

Sleep disorders threaten kids with premature heart disease and stroke

Poor sleep patterns and lack of proper sleep could be threatening thousands of Canadian adolescents with premature heart disease and stroke, warns Heart and Stroke Foundation researcher Dr. Brian McCrindle, a pediatric cardiologist at the Hospital for Sick Children in Toronto.

26 Oct 2010

Pre-retirees concerned over rising healthcare costs

Nearly two-thirds (62 percent) of pre-retirees ages 50-64 are not at all confident that they are saving enough to handle healthcare costs in retirement, according to a new survey from the Society of Actuaries (SOA). Additionally, only seven percent of participants said they are very confident about having enough savings.

26 Oct 2010

AAHP highlights safety of homeopathic children's medicines

The American Association of Homeopathic Pharmacists (AAHP), representing the major manufacturers and distributors of homeopathic drugs, highlights the safety of homeopathic children's medicines in response to the recall of Hyland's Teething Tablets. The AAHP supports the efforts to protect the safety of children by both the Standard Homeopathic Company and the U.S. Food and Drug Administration (FDA).

26 Oct 2010

John Theurer Cancer Center unveils new $130M, 155,000-square-foot comprehensive facility

The John Theurer Cancer Center at Hackensack University Medical Center unveiled a new $130-million, 155,000-square-foot comprehensive cancer facility that will enhance the cancer center's ability to deliver multidisciplinary extraordinary care, best-in-class clinical quality, and cutting-edge research. The doors will open for patients in January 2011.

26 Oct 2010

Healthcare News and Research

Latest Healthcare News and Research

Kinetic Concepts 2010 third quarter total revenue increases 2% to $506.7 million

Prevention of vascular diseases needed to avoid tsunami of cases

PharmaVentures acts as advisor and broker to Dr Reddy's in distribution agreement with Vitabiotics

MDI and Westburg enter exclusive distribution agreement for Detect-Ready MRSA panel in Benelux region

Centene third quarter premium and service revenues increase 9.5% to $1.082 billion

Admissions for medication, drug-related conditions increase by 117% among Americans aged 45 and older

Omeros to develop new drugs for major diseases

New Risk Stratification Index allows important clinical outcomes

Pfizer's Sutent stands as first-line setting for treating renal cell carcinoma: Survey

Challenges in overcoming communication barriers when treating non-Swedish-speaking patients

Francisco Partners to invest in Quantros

IDC grants MedImmune global rights to GLA adjuvant

DKSH’s distribution centers achieve GMP/GDP certification

Beryl redefines focus as patient experience company

Knowledge gaps and unjustified fear common among caregivers of children with MRSA

Barbers help customers control high blood pressure

Sleep disorders threaten kids with premature heart disease and stroke

Pre-retirees concerned over rising healthcare costs

AAHP highlights safety of homeopathic children's medicines

John Theurer Cancer Center unveils new $130M, 155,000-square-foot comprehensive facility

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Healthcare News and Research

Latest Healthcare News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in